5-fluorodopamine has been researched along with Neuroendocrine Tumors in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karges, W; Mottaghy, FM; Van Binnebeek, S | 1 |
| Gesuwan, K; Herscovitch, P; Hughes, MS; Kebebew, E; Kitano, M; Libutti, SK; Linehan, WM; Millo, C; Nilubol, N; Phan, GQ; Rahbari, R; Venkatesan, AM; Webb, RC | 1 |
| Arola, J; Asa, SL; Sane, T; Schalin-Jäntti, C | 1 |
1 trial(s) available for 5-fluorodopamine and Neuroendocrine Tumors
| Article | Year |
|---|---|
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
Topics: Adolescent; Adult; Aged; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; von Hippel-Lindau Disease; Young Adult | 2011 |
2 other study(ies) available for 5-fluorodopamine and Neuroendocrine Tumors
| Article | Year |
|---|---|
Functional imaging of neuroendocrine tumors.
Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin | 2011 |
Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushing Syndrome; Disease Progression; Dopamine; Humans; Hydrocortisone; Ki-67 Antigen; Male; Neuroendocrine Tumors; Radiopharmaceuticals; Thymus Neoplasms | 2013 |